key: cord-0920539-rpcseozn
authors: Tan, Rayner K. J.; Wu, Dan; Day, Suzanne; Zhao, Yang; Larson, Heidi J.; Sylvia, Sean; Tang, Weiming; Tucker, Joseph D.
title: Digital approaches to enhancing community engagement in clinical trials
date: 2022-03-25
journal: NPJ Digit Med
DOI: 10.1038/s41746-022-00581-1
sha: c40afa70b67528889d19c3d6952667e61e87c1b1
doc_id: 920539
cord_uid: rpcseozn

Digital approaches are increasingly common in clinical trial recruitment, retention, analysis, and dissemination. Community engagement processes have contributed to the successful implementation of clinical trials and are crucial in enhancing equity in trials. However, few studies focus on how digital approaches can be implemented to enhance community engagement in clinical trials. This narrative review examines three key areas for digital approaches to deepen community engagement in clinical trials—the use of digital technology for trial processes to decentralize trials, digital crowdsourcing to develop trial components, and digital qualitative research methods. We highlight how digital approaches enhanced community engagement through a greater diversity of participants, and deepened community engagement through the decentralization of research processes. We discuss new possibilities that digital technologies offer for community engagement, and highlight potential strengths, weaknesses, and practical considerations. We argue that strengthening community engagement using a digital approach can enhance equity and improve health outcomes.

Technological advances in the past decades have brought about the rise of digital research methods in health, which have been defined as research that involves the use of the internet, or research that is embedded in online devices 1 . This has also led to the growth of the field of digital health, which the World Health Organization (WHO) defines as the use of digital and mobile technologies to support health system needs. Recognizing the emergence of digitization in both health systems functioning and research, the WHO released the first evidence-based guidelines on digital health in 2019, which discusses research considerations for digital health interventions 2 . This is especially pertinent given the growing trend in connected technologies and digital products 3 . Although much has been written about the digitization of clinical trials in the areas of community recruitment, retention, data collection, and analytic approaches 4, 5 , less research has considered how technology can be used to optimize community engagement in clinical trials.

Community engagement has been defined as "the process of working collaboratively with groups of people who are affiliated by geographic proximity, special interests, or similar situations with respect to issues affecting their well-being" 6 . Optimizing the breadth and depth of community engagement goes beyond asking patient representatives about appropriate incentives to participate and other recruitment-focused questions. A continuum of community engagement has been proposed by the United States Department of Health & Human Services, with increasing engagement characterized by community involvement, impact, trust and communication flow spanning from outreach (least engaged), consult, involve, collaborate, and shared leadership (most engaged) 7 .

International organizations like UNAIDS and WHO have underlined the importance of community engagement in clinical trials 8, 9 . Community engagement processes have contributed to the successful implementation of trials by helping to identify digital health measures that are relevant to patients and communities, and address barriers to recruitment and implementation of trial components [10] [11] [12] . These are especially important given implementation challenges such as mistrust in research, low levels of participation, and insufficient uptake of research findings in communities 13 . Community engagement in research can also be seen as an ethical imperative. Early oral tenofovir trials for HIV pre-exposure prophylaxis among marginalized communities in Cambodia, Cameroon, Nigeria, Malawi, and Thailand drew international attention with concerns over ethical violations in research practices as a result of shortcomings in community engagement 14 .

Given the importance of community engagement in clinical trials, our efforts to digitize research processes in clinical trials should also be reflected in our efforts to strengthen community engagement in such trials. Digital approaches to community engagement are especially important for two reasons. First, the COVID-19 pandemic has led to the transition of many traditionally in-person community engagement activities towards digital adaptations. This trend has accelerated the growth of digital research methods and the implementation of digital health innovations. Second, in the context of digital clinical trials, while technological innovations hold promise in scaling up and improving precision of clinical trials, technological advances alone do not guarantee equitable health outcomes. Many people are inadvertently excluded from digital clinical trial participation, despite being digitally connected, eager, and willing to contribute 15, 16 . Rapid digitization without consideration for community engagement processes may therefore result in deepening health inequities.

The purpose of this narrative review is to examine the areas where digital methods have been adopted in clinical trials, and how they have helped enhance community engagement. To identify relevant papers, a search of PubMed was conducted in June 2021 using the following search terms: (digital OR online) AND (community engagement OR equity OR crowdsourcing OR research methods) AND (clinical trial* OR experiment* OR intervention*). Only papers published in English were reviewed, and after reviewing existing studies, digital approaches to enhancing community engagement in trials are discussed. Through our review, we noted that studies utilizing digital approaches that discussed its implications for community engagement or participant equity revolved about the digitization of trial processes, the use of online crowdsourcing methods, as well as online qualitative research methods in trial contexts. We selected these three areas of focus as well because of their importance within WHO frameworks, relevance to digital community engagement, and potential impact on health equity 17, 18 . Consequently, the three areas of focus for our review include (i) the use of digital technologies to implement trial components, (ii) digital crowdsourcing to develop trial components, and (iii) the use of digital qualitative research methods for community engagement.

Digitization of clinical trial processes can enhance community engagement by improving representation of participants, generalizability of results, and equity of outcomes through the decentralization of trial processes. Digitization of clinical trials involves the use of technology for the implementation of trial processes, which include eligibility assessment and consent in recruitment, allocation, intervention, outcome assessment, and dissemination of findings 4, 19 . Such digitization processes are becoming increasingly common as the COVID-19 pandemic has driven many clinical trials to embrace online components in whole or in part as a result of policies that have limited in-person interactions, and encouraged digital assessments within clinical trials. Some in-person interventions have been entirely transitioned into online formats in response to COVID-19 20 .

Technology can be employed in clinical trial implementation procedures in ways that will enhance community engagement and equity. First, digital clinical trials have the potential to be more inclusive in terms of the communities that are engaged, as well as allow for decentralization of trial processes and reduce costs. Specifically, digital recruitment of participants may include marginalized people who live in rural areas who may have greater difficulty travelling to clinical trial sites at academic medical centers, which allow for a broadening of recruitment criteria to include participants regardless of where they reside or work 4 . For example, a crowdsourcing contest that solicited online submissions in Eswatini saw substantial participation from participants in rural areas by combining online participation with offline promotional methods 21 . In the United States, a similar crowdsourcing approach to garner online community feedback on HIV clinical trial processes saw participation from more women, more racial and ethnic minorities, and more low-income individuals compared to a traditional community advisory board (CAB) approach 22 . Second, technological implementations also allow for capturing data from digital interventions that are often decentralized and not attached to specific clinical settings, including objective data on behavior or biological measurements, reducing the need for participants to travel to clinical settings for participation. For example, a randomized trial evaluating a mobile phone application detecting potential arrhythmias enrolled 419,297 participants who were not required to attend a clinic 23 . This included participation from typically underrepresented groups in clinical trial studies 24 , such as racial or ethnic minorities (32% were non-white) and those who are older (10% were 55-64 years old; 5.9% were 65 years old and above). Furthermore, the use of wearables like activity trackers and smartwatches has shown promise in the fight against COVID-19 25, 26 , and may pave the way for more inclusive participation if made available to a diverse population. Finally, digital clinical trials may reduce costs associated with recruitment and retention compared to conventional in-person trial designs 4 , and therefore costs for participants as well.

Despite these benefits for community engagement, there are also weaknesses associated with digital technologies when implementing trial components or processes. First, the persistence of a digital divide excludes populations from participating in such digital activities 27 . Often older people, people with disabilities, and financially disadvantaged people are digitally excluded. Second, self-reporting is a source of potential bias in online surveys that may be used for assessments in clinical trials, as opposed to surveyor-administered surveys in clinic settings. Smartphone photo-verification of some outcomes (e.g., self-test completion) can decrease reliance on self-report 28 . Third, in trials that evaluate social media messages, contamination between study arms is a potential problem. Such messages could be shared online, exposing participants in the control arm to the intervention 29 . Methods to decrease contamination include limiting exposure to intervention messages in the setting of closed private groups, sending messages that cannot be saved or shared, and limited intervention exposure to in-person settings. In addition, verification of human participants is important and can be achieved through simple CAPTCHA (Completely Automated Public Turing test to tell Computers and Humans Apart) widgets. Finally, there is at present few mandatory reporting standards for the use of digital health-specific research checklists, in spite of the availability of one research checklist for digital survey studies 30 , and a CONSORT eHealth checklist for digital health interventions 31 . Nevertheless, efforts are being made to improve standards around the design and reporting of digital trials, such as The Clinical Trials Transformation Initiative's digital health trials program focused on decentralized clinical trials, novel endpoints, engaging patients, and technology 32 .

Digital crowdsourcing processes present opportunities to enhance diversity in representation not just among trial participants, but for community input and engagement processes in the design of clinical trials. Crowdsourcing activities are increasingly used in digital health research 33 , and typically involves a group of diverse individuals contributing to solving a health problem and then sharing identified solutions with key stakeholders 34 . This in turn may help tailor health programs to the needs of end users to improve acceptance, and limit the homogeneity of interventions developed using a top-down approach. Crowdsourcing is often implemented using digital technologies, and as such may provide an important opportunity to fill the gap in community engagement in clinical trials. This may be achieved specifically through open calls for clinical trial intervention materials, as well as the use of digital hackathons to further develop crowdsourced ideas.

Open calls and hackathons are crowdsourcing activities that can be implemented on digital platforms and used for participatory development of clinical trial components 35 . Evidence suggests that crowdsourced interventions are potentially superior to conventional approaches, in improving health outcomes. Examples include the superiority of crowdsourced methods in developing sexual health intervention material by the general public vis-à-vis those developed by experts 35, 36 . Promotional events can be conducted online using websites, email dissemination, social media platforms, such as Facebook, WeChat 37 , or TikTok 38 . For example, TikTok users participated in a crowdsourcing open call to identify a user-friendly medicine bottle design for people living with Parkinson's disease 38 .

In addition to open calls, digital hackathons are another form of crowdsourcing that can further increase community engagement in clinical trials 39 . Digital hackathons typically involve an open call for submissions, which lead up to intensive activities that bring people together via online platforms to complete a specific task within several days 35 . Digital hackathons can foster interdisciplinary collaboration, and lead to rapid innovations for clinical trials to tackle health challenges. For example, digital hackathons have been implemented in response to the COVID-19 pandemic to crowdsource challenges faced by individuals from public, private, and non-governmental organizations in the pandemic, and to generate rapid solutions to address urgent and unmet needs that have arose [39] [40] [41] . Apart from generating innovative ideas for evaluation in clinical trials, hackathons have been used to refine and determine optimal implementation strategies for trials 35 . Previous research has shown that hackathons can take ideas solicited via an open call forward and optimize public health campaign messages, which are proven non-inferior to conventional expert driven interventions as part of a clinical trial 42, 43 .

Crowdsourcing techniques that comprise digital channels for participation can also complement existing CAB arrangements to broaden stakeholder feedback. CABs are typically composed of individual stakeholders who reflect the community of interest, and serve as a source of leadership to guide research activities and trial procedures 44 . The US National Institutes of Mental Health first required CABs to enhance community engagement in HIV research in 1987 45 . A study comparing levels of engagement between a traditional CAB and crowdsourced wisdom found that crowdsourcing may deepen engagement and inclusion of community voices, especially among unemployed individuals and people with disabilities 22 .

Crowdsourcing activities have several advantages. By engaging a group of people with diverse backgrounds, crowdsourcing may have higher potential for innovation due to multi-sectoral, interdisciplinary contributions to creating culturally appropriate solutions that may inform the design and implementation of clinical trials 35, 36 . Digital approaches to crowdsourcing can further increase the scale of the event, amplify the reach of audience and the diversity of cultural backgrounds of participants by breaking physical barriers, especially where access to in-person events may serve as an even larger barrier to participation among such marginalized groups, rather than the need for technical assistance 22 . To mitigate limited participation from marginalized subgroups as a result of individual and structural barriers, strategies for engagement need to be sensitive to availability and distribution of technology among participants. For example, framing the topic as broadly relevant to key communities and allowing the use of audio and video clips, images, and texts, or other artistic formats may enable people to create a submission in their own way, including those with disabilities 46 . Flexibility in submission channels can also be considered such as allowing participants who encounter difficulties in submitting via a survey link to send their entries via social media apps or emails 47 .

On the other hand, while digital crowdsourcing activities have successfully been implemented in low-and middle-income countries (LMICs) 48 , limited access to technology may be a barrier to participation. It is therefore important for researchers to examine the digital ecosystem and structures of a particular context before implementing digital crowdsourcing approaches to avoid such selection biases that contribute to the digital divides. For example, past crowdsourcing activities in LMICs have considered barriers to participation such as internet bandwidth issues, and have adopted asynchronous digital technologies and social media apps, such as Facebook, WhatsApp, and WeChat, can be leveraged to organize and promote the crowdsourcing activities 21 . Furthermore, digital crowdsourcing methods can be complemented by CABs or co-creation group efforts to enhance community engagement, given that CAB members may be more familiar with trial processes and are better positioned to identify broader institutional or systemic concerns inherent to trials 22 .

Digital qualitative methods can be used in clinical trial processes to enhance representation in formative and process evaluation research for clinical trials, as well as lend greater ecological validity to research findings due to the decentralized nature of such approaches. Past work has established how such methods are well-suited to address important questions that may arise in formative clinical trial research and in the implementation sciences, such as exploring the multi-faceted contexts where implementation takes place, the processes and steps involved in implementation, as well as the effectiveness of implementation strategies 49 . In the context of formative research, studies have shown that formative qualitative research can help assess the usability, feasibility, acceptance, and impact of potential digital health interventions 50 , and for the reasons mentioned above, can help improve representation and ecological validity for the implementation of clinical trial components. In the context of process evaluation, past studies using digital storytelling have found such techniques are useful to elicit both visual and textual representations of lived experiences and the contexts in which participants are embedded in 51, 52 , which are useful for understanding how interventions in clinical trials may work, for whom, and under what contexts 53 .

While COVID-19 has disrupted the ways such methods have traditionally been conducted in-person due to movement control measures and the risks of in-person participation, it has also given us the opportunity to focus and expand on existing digital qualitative methods. This includes data collection by telephone, text 54 , and videoconference 55 . Digital forms of focus group discussions (FGDs) have also emerged, starting with the use of emails, online forums and message boards 56 , and later, virtual discussion rooms which bear a strong resemblance to traditional focus groups in their synchronous nature but also rely on text-based nonverbal communication and discussion 57 . More recently, scholars have also used teleconferencing software and chat apps such as WhatsApp to conduct both asynchronous and synchronous FGDs 58 . Traditional participant observation methods have also evolved towards innovative approaches such as cyber-ethnography, as well as participant-led methods like photovoice, that provide promising advances in social methodology and inquiry 59, 60 .

Community engagement using digital qualitative methods have several benefits for clinical trials. First, digital platforms may help deepen community engagement by creating safer environments or spaces for community engagement, and foster more authentic feedback from community members. For example, online chatbased FGDs may facilitate the sharing of sensitive information from, or disagreements among participants due to the absence of nonverbal cues, as such cues may inform perceived power differences among participants 61, 62 . Chat-based mobile phone apps also offer high ecological validity due to their embeddedness in individuals' everyday lives 63 . The anonymous nature of online spaces may increase trust in cyber-ethnography compared to other engagement methods because of the lower risk of selfdisclosure and resulting safe space 64 .

Second, digital qualitative methods also offer logistical advantages for inclusivity, thus deepening engagement through greater representation and diversity among participants.

For example, online FGDs can be more inclusive in terms of recruiting a diverse range of participants who may face access issues when getting to physical locations 65 . The use of digital qualitative methods may also save time and costs for researchers who do not have to pay for in-person venue rental fees, transportation, and transcription in some cases 58, 66 . Digital qualitative methods also decrease COVID-19 risks associated with conventional in-person qualitative methods 67 .

Nevertheless, there are several drawbacks of community engagement using digital qualitative methods, which may have implications for the implementation of clinical trials. With regard to the depth of data generated, researchers have found that online chat-based interviews and FGDs tended to generate lower word counts, shorter responses, and provided less detail or richness 57, 61, 68, 69 . The lag time between responses, as well as the lack of an ability to sense emotions such as sarcasm or the use of metaphor may lead to ambiguity in interaction 70 . Online chat-based FGDs also tended to have fewer group interactions and lower responsiveness to facilitators' questions and probes 57, 62, 68 . While videoconferencing software has allowed for an approximation of in-person interviews and FGDs, researchers may encounter difficulties with disruptive environments, the loss of concentration, as well as a lack of nonverbal cues and body language 55, 71 . Ethical issues may also arise with methods such as cyber-ethnography, where informed consent may be difficult to obtain from participants due to the often unobtrusive and covert nature of cyber-ethnographic approaches 72 .

We present a summary of how the three digital approaches highlighted above can be applied throughout the life course of clinical trials (Table 1) . Enhancing community engagement through digital approaches can support equitable processes and outcomes in clinical trials. Our review highlights how digital technologies not only provide an alternative means of engaging participants in trials but also provide unique information to enhance clinical trials. These generally include the ability to engage participants and experts in multiple settings, regardless of geography and nationality through the use of digital technologies, reduced costs associated with the use of such online or digital components, and opportunities to democratize trial design processes. While digital approaches employed in clinical trials have a potentially wider reach than in-person trials, they can exacerbate health inequities if care is not taken to ensure that the inclusive potential of such approaches are realized. Mobile phone subscriptions may be rising globally, including LMICs; however, mobile network coverage has been found to be lower and more expensive in the least developed countries of the world 73 . And while mobile phone subscriptions are rising rapidly across the world, the same cannot be said about access to the internet, where mobile and fixed broadband subscriptions per capita are lagging behind in developing economies, compared to the rest of the world 27, 74 . The lack of consideration in the design of interventions and commercial products for those with limited access to broadband or internet bandwidth may also exacerbate such inequities 75 . Furthermore, beyond the availability of technology, past studies evaluating the effectiveness of digital health services in a given context have shown that social determinants of health including socioeconomic status, demographic attributes, and levels of health literacy impact one's access to digital health interventions and thus engagement in clinical trials 76 .

Digital access has become a social determinant of health with increasing salience amidst the COVID-19 pandemic, as health information and interventions are increasingly being rolled out and implemented online, leaving the most vulnerable behind 77 . We present an adapted socio-ecological model (Fig. 1) which underscores important considerations at the individual, interpersonal, organizational, community, and policy levels for digital engagement strategies that clinical trials should consider. We also present several recommendations for clinical trials to enhance community engagement in these areas, including personcentered strategies at the individual level, sensitivities to digitally mediated interactions at the interpersonal level, ensuring organizational capacity through specialized training or allowing for flexible hybrid models of engagement at the organizational level, sensitivities to community norms and ecologies at the community level, and ensuring availability of resources and alignment with legal and regulatory frameworks at the policy and institutional level. 80 . Potential safeguards include limiting the identifying information collected as part of digital engagement and not requiring the use of real names when taking part in studies, allowing participants to opt out of specific questions and still join a study or engagement project, and cocreating study protocols with communities in considering the ethics and study design to minimize potential risks. Risk mitigation strategies for crowdsourcing contests and innovation challenges have also been detailed elsewhere 81 . Regulatory hurdles may also need to be addressed to facilitate community engagement through digital approaches. Specifically, existing regulatory frameworks such as those that govern the use of digital platforms, medical devices or therapeutic approaches may not be favorable for novel approaches in digital health, therefore posing barriers to innovation and adoption 82 . Regulatory innovations, including regular adjustments to frameworks or regulatory flexibilities in emergency situations 83 , are required by governance structures to ensure that digital innovations suggested in this article can be effectively implemented. Such regulatory innovations have been effectively implemented in the COVID-19 pandemic without compromising on patient safety or product quality [83] [84] [85] . Additionally, regulatory frameworks that govern research practices or community engagement in trials may also require further review to ensure that research protocols are aligned with practices that uphold patient privacy and safety in the context of novel digital approaches 86, 87 .

In conclusion, digital approaches can help to promote health equity in digital clinical trials in several ways (Table 2 ). In Table 2 , we also provide examples of each digital approach and describe how they had enhanced community engagement.

This narrative review highlighted potential strengths and weaknesses across three broad digital engagement strategies. However, a digital divide and barriers owing to participant privacy and regulatory hurdles remain, which threaten the implementation of such digital approaches. Nevertheless, research has demonstrated that digital approaches can enhance equity in clinical trials and be modified in ways that are sensitive to local access to digital technologies, which may be more heterogeneous in LMICs where access to affordable mobile data and broadband are limited.

This narrative review also provides trial researchers and implementation scientists strategies to deepen community engagement in clinical trials. For researchers engaged in clinical trials that already adopt community engagement processes in their work, digital approaches provide ways to enhance equity and more broadly engage communities. For clinical trial researchers who have not yet adopted community engagement techniques, digital methods for engaging communities should be considered. Regulators and expert committees should also consider providing recommendations on the benefits and limitations of such digital approaches to engaging communities in clinical trial research as future considerations in clinical trial frameworks.

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

All data generated or analyzed during this study are included in this published article. All aggregate data collected for this Review are available from the corresponding author on reasonable request.

World Health Organization. WHO Guideline: Recommendations on Digital Interventions for Health System Strengthening

Quantifying the use of connected digital products in clinical research

A decade of digital medicine innovation

Good participatory practice guidelines for biomedical HIV prevention trials

Good participatory practice guidelines for trials of emerging (and reemerging) pathogens that are likely to cause severe outbreaks in the near future and for which few or no medical countermeasures exist (GPP-EP). (World Health Organization

Case Study: Community engagement and clinical trial success: outreach to African American Women

Engaging diverse communities participating in clinical trials: case examples from across Africa

Digital measures that matter to patients: a framework to guide the selection and development of digital measures of health

Why we need community engagement in medical research

Community Inclusion in PrEP Demonstration Projects: Lessons for Scaling Up

Overcoming barriers to clinical trial enrollment

Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement

World Health Organization. Global strategy on digital health 2020-2025. (World Health Organization

Community engagement: a health promotion guide for universal health coverage in the hands of the people. (World Health Organization

Internet-based randomized controlled trials: a systematic review

The healing hearts together randomized controlled trial and the COVID-19 pandemic: a tutorial for transitioning from an in-person to a web-based intervention

Increasing men's engagement in HIV testing and treatment programs through crowdsourcing: a mixed methods analysis in Eswatini

Expanding community engagement in HIV clinical trials: a pilot study using crowdsourcing

Large-scale assessment of a smartwatch to identify atrial fibrillation

Representation in clinical trials: a review on reaching underrepresented populations in research

Wearables to fight COVID-19: From symptom tracking to contact tracing

Wearable devices for the detection of COVID-19

Bridging the digital divide in health care

Verification of HIV self-testing use and results: a global systematic review

A crowdsourced intervention to promote hepatitis B and C testing among men who have sex with men in China: a nationwide online randomized controlled trial

Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)

CONSORT-EHEALTH: improving and standardizing evaluation reports of Web-based and mobile health interventions

Crowdsourcing in health and medical research: a systematic review

Crowdsourcing in medical research: concepts and applications

Crowdsourcing methods to enhance HIV and sexual health services: a scoping review and qualitative synthesis

Crowdsourcing to improve HIV and sexual health outcomes: a scoping review

Crowdsourcing in Health and Health Research: A Practical Guide

Parkinson's meds are hard to grab, so Tiktok users crowdsourced a solution

Interdisciplinary online hackathons as an approach to combat the COVID-19 pandemic: case study

Successful models of hackathons and innovation contests to crowdsource rapid responses to COVID-19

Virtual hackathon to tackle COVID-19 unmet needs

Crowdsourcing HIV test promotion videos: a noninferiority randomized controlled trial in China

Crowdsourcing to expand HIV testing among men who have sex with men in China: a closed cohort stepped wedge cluster randomized controlled trial

Community advisory boards in community-based participatory research: a synthesis of best processes

Stakeholder engagement to inform HIV clinical trials: a systematic review of the evidence

Crowdsourcing and community engagement: a qualitative analysis of the 2BeatHIV contest

The 4 youth by youth HIV self-testing crowdsourcing contest: a qualitative evaluation

A designathon to co-create community-driven HIV self-testing services for Nigerian youth: findings from a participatory event

Qualitative methods in implementation research: an introduction

Methods and Evaluation criteria for apps and digital interventions for diabetes self-management: systematic review

Engaging elements of cancer-related digital stories in Alaska

Visual ethnography and refugee women: nuanced understandings of lived experiences

Realistic Evaluation

Handbook of Interview Research: Context & Method

Skype interviewing: the new generation of online synchronous interview in qualitative research

Researching online populations: the use of online focus groups for social research

A critical comparison of offline focus groups, online focus groups and e-Delphi

Texting the waters: an assessment of focus groups conducted via the WhatsApp smartphone messaging application

The biotechnical embrace

Photovoice: concept, methodology, and use for participatory needs assessment

Characteristics of the discussion in online and face-to-face focus groups

In-person versus online focus group discussions: a comparative analysis of data quality

Using WhatsApp for focus group discussions: ecological validity, inclusion and deliberation

From lay depression narratives to secular ritual healing: an online ethnography of mental health forums

Online facebook focus group research of hardto-reach participants

It's More Complicated Than It Seems: Virtual Qualitative Research in the COVID-19 Era

Data richness trade-offs between face-to-face, online audiovisual, and online text-only focus groups

Online interviewing in psychology: reflections on the process

Reflecting on the experience of interviewing online: perspectives from the Internet and HIV study in London

The use of videoconferencing for qualitative interviewing: opportunities, challenges, and considerations

Handbook of Research on Methods and Techniques for Studying Virtual Communities: Paradigms and Phenomena

United Nations Conference on Trade and Development. Least developed countries suffer digital divide in mobile connectivity

United Nations Conference on Trade and Development. Digitalization offers great potential for development, but also risks

United Nations Conference on Trade and Development

Digital health and inequalities in access to health services in Bangladesh: mixed methods study

The expanding digital divide: digital health access inequities during the COVID-19 pandemic in New York City

Rethinking patient data privacy in the era of digital health

How to use relevant data for maximal benefit with minimal risk: digital health data governance to protect vulnerable populations in low-income and middle-income countries

Privacy in a Digital

Ethical concerns of and risk mitigation strategies for crowdsourcing contests and innovation challenges: scoping review

Characteristics and challenges of the clinical pipeline of digital therapeutics

Advancing digital health: FDA innovation during COVID-19. npj Digital Med

Food and Drug Administration. Digital Health Policies and Public Health Solutions for COVID-19

Enforcement Policy for Digital Health Devices For Treating Psychiatric Disorders During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

Big data, biomedical research, and ethics review: new challenges for IRBs

The SAGE handbook of qualitative data collection

Zoom interviews: benefits and concessions

First draft was written by R.T., D.W., and J.T. All other authors contributed additional content, edits, and references. All authors approved the final draft.

The authors declare no competing interests.

Supplementary information The online version contains supplementary material available at https://doi.org/10.1038/s41746-022-00581-1.Correspondence and requests for materials should be addressed to Rayner K. J. Tan.

Publisher's note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons. org/licenses/by/4.0/.